Publication & Citation Trends
Publications
0 total
Abstract 324: Discovery of novel functional TROP2 antibodies for treatment of epithelial cancers
Cited by 0
Semantic Scholar
Abstract P200: Pre-clinical development of a dopamine receptor 2, PD-1 and CD47 trispecific antibody for treatment of small cell lung cancer
Cited by 1
Semantic Scholar
Abstract LB094: KisoBody: Development and pre-clinical assessment of a novel multispecific antibody platform
Cited by 0
Semantic Scholar
Abstract LBA018: Discovery of novel functional TROP2 antibodies for treatment of epithelial cancers
Cited by 0
Semantic Scholar
488. Development of a Robust Non-Viral Gene Delivery System for Gut Mucosal Cells OA
Cited by 0
Semantic Scholar
Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies.
Cited by 5
Semantic Scholar
A Phase I, Dose-Escalation Study of Mgcd265, A Multi-Targeted Oral Tyrosine Kinase Receptor Inhibitor, for Treatment of Advanced Solid Tumors OA
Cited by 0
Semantic Scholar
Abstract 1790: The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis
Cited by 16
Semantic Scholar
Research Topics
Histone Deacetylase Inhibitors Research
(16)
Protein Degradation and Inhibitors
(13)
Cancer, Hypoxia, and Metabolism
(7)
Epigenetics and DNA Methylation
(6)
Microtubule and mitosis dynamics
(5)
Affiliations
Cégep de Saint-Laurent
Vancouver Clinic
Pyrogenesis (Canada)
Biotechnology Research Institute
Molecular Biology Consortium